Neuland Laboratories Limited

NSEI:NEULANDLAB Stock Report

Market Cap: ₹142.1b

Neuland Laboratories Management

Management criteria checks 2/4

Neuland Laboratories' CEO is Davuluri Rao, appointed in Aug 2013, has a tenure of 21.08 years. total yearly compensation is ₹148.30M, comprised of 16.3% salary and 83.7% bonuses, including company stock and options. directly owns 3.3% of the company’s shares, worth ₹4.69B. The average tenure of the management team and the board of directors is 3.9 years and 9.3 years respectively.

Key information

Davuluri Rao

Chief executive officer

₹148.3m

Total compensation

CEO salary percentage16.3%
CEO tenure11yrs
CEO ownership3.3%
Management average tenure3.9yrs
Board average tenure9.3yrs

Recent management updates

Recent updates

Is Now The Time To Put Neuland Laboratories (NSE:NEULANDLAB) On Your Watchlist?

Aug 02
Is Now The Time To Put Neuland Laboratories (NSE:NEULANDLAB) On Your Watchlist?

Neuland Laboratories' (NSE:NEULANDLAB) Dividend Will Be Increased To ₹14.00

Jul 12
Neuland Laboratories' (NSE:NEULANDLAB) Dividend Will Be Increased To ₹14.00

Optimistic Investors Push Neuland Laboratories Limited (NSE:NEULANDLAB) Shares Up 28% But Growth Is Lacking

Jul 02
Optimistic Investors Push Neuland Laboratories Limited (NSE:NEULANDLAB) Shares Up 28% But Growth Is Lacking

Neuland Laboratories' (NSE:NEULANDLAB) Upcoming Dividend Will Be Larger Than Last Year's

Jun 19
Neuland Laboratories' (NSE:NEULANDLAB) Upcoming Dividend Will Be Larger Than Last Year's

Is Neuland Laboratories (NSE:NEULANDLAB) Using Too Much Debt?

Jun 12
Is Neuland Laboratories (NSE:NEULANDLAB) Using Too Much Debt?

Neuland Laboratories (NSE:NEULANDLAB) Will Pay A Larger Dividend Than Last Year At ₹14.00

May 21
Neuland Laboratories (NSE:NEULANDLAB) Will Pay A Larger Dividend Than Last Year At ₹14.00

There's Reason For Concern Over Neuland Laboratories Limited's (NSE:NEULANDLAB) Massive 25% Price Jump

Apr 19
There's Reason For Concern Over Neuland Laboratories Limited's (NSE:NEULANDLAB) Massive 25% Price Jump

We Ran A Stock Scan For Earnings Growth And Neuland Laboratories (NSE:NEULANDLAB) Passed With Ease

Apr 15
We Ran A Stock Scan For Earnings Growth And Neuland Laboratories (NSE:NEULANDLAB) Passed With Ease

Subdued Growth No Barrier To Neuland Laboratories Limited (NSE:NEULANDLAB) With Shares Advancing 29%

Feb 17
Subdued Growth No Barrier To Neuland Laboratories Limited (NSE:NEULANDLAB) With Shares Advancing 29%

Revenue Beat: Neuland Laboratories Limited Exceeded Revenue Forecasts By 8.1% And Analysts Are Updating Their Estimates

Feb 12
Revenue Beat: Neuland Laboratories Limited Exceeded Revenue Forecasts By 8.1% And Analysts Are Updating Their Estimates

Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly

Jan 05
Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly

The Neuland Laboratories Limited (NSE:NEULANDLAB) Analyst Just Boosted Their Forecasts By A Meaningful Amount

Nov 12
The Neuland Laboratories Limited (NSE:NEULANDLAB) Analyst Just Boosted Their Forecasts By A Meaningful Amount

Here's Why We Think Neuland Laboratories (NSE:NEULANDLAB) Might Deserve Your Attention Today

Oct 27
Here's Why We Think Neuland Laboratories (NSE:NEULANDLAB) Might Deserve Your Attention Today

Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly

Aug 24
Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly

Forecast: Analysts Think Neuland Laboratories Limited's (NSE:NEULANDLAB) Business Prospects Have Improved Drastically

Aug 05
Forecast: Analysts Think Neuland Laboratories Limited's (NSE:NEULANDLAB) Business Prospects Have Improved Drastically

Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00

Jul 05
Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00

Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00

Jun 21
Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00

Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00

May 14
Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00

Should You Be Adding Neuland Laboratories (NSE:NEULANDLAB) To Your Watchlist Today?

May 12
Should You Be Adding Neuland Laboratories (NSE:NEULANDLAB) To Your Watchlist Today?

Here's Why Neuland Laboratories (NSE:NEULANDLAB) Can Manage Its Debt Responsibly

Aug 30
Here's Why Neuland Laboratories (NSE:NEULANDLAB) Can Manage Its Debt Responsibly

I Built A List Of Growing Companies And Neuland Laboratories (NSE:NEULANDLAB) Made The Cut

Feb 23
I Built A List Of Growing Companies And Neuland Laboratories (NSE:NEULANDLAB) Made The Cut

The Consensus EPS Estimates For Neuland Laboratories Limited (NSE:NEULANDLAB) Just Fell Dramatically

Feb 03
The Consensus EPS Estimates For Neuland Laboratories Limited (NSE:NEULANDLAB) Just Fell Dramatically

Neuland Laboratories (NSE:NEULANDLAB) Has A Pretty Healthy Balance Sheet

Mar 15
Neuland Laboratories (NSE:NEULANDLAB) Has A Pretty Healthy Balance Sheet

CEO Compensation Analysis

How has Davuluri Rao's remuneration changed compared to Neuland Laboratories's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

₹3b

Mar 31 2024₹148m₹24m

₹3b

Dec 31 2023n/an/a

₹3b

Sep 30 2023n/an/a

₹3b

Jun 30 2023n/an/a

₹2b

Mar 31 2023₹58m₹20m

₹2b

Dec 31 2022n/an/a

₹1b

Sep 30 2022n/an/a

₹831m

Jun 30 2022n/an/a

₹651m

Mar 31 2022₹30m₹15m

₹638m

Dec 31 2021n/an/a

₹593m

Sep 30 2021n/an/a

₹731m

Jun 30 2021n/an/a

₹742m

Mar 31 2021₹34m₹11m

₹806m

Dec 31 2020n/an/a

₹540m

Sep 30 2020n/an/a

₹384m

Jun 30 2020n/an/a

₹257m

Mar 31 2020₹22m₹10m

₹162m

Dec 31 2019n/an/a

₹321m

Sep 30 2019n/an/a

₹257m

Jun 30 2019n/an/a

₹216m

Mar 31 2019₹13m₹10m

₹164m

Mar 31 2018₹5m₹3m

₹121m

Compensation vs Market: Davuluri's total compensation ($USD1.77M) is above average for companies of similar size in the Indian market ($USD474.53K).

Compensation vs Earnings: Davuluri's compensation has increased by more than 20% in the past year.

CEO

Davuluri Rao (49 yo)

11yrs

Tenure

₹148,300,000

Compensation

Mr. Davuluri Sucheth Rao has been the Chief Executive Officer of Neuland Laboratories Limited since August 1, 2013, where Mr. Rao also served as its Chief Operating Officer. At Neuland, Sucheth has been re...

Leadership Team

NamePositionTenureCompensationOwnership
Davuluri Rama Rao
Executive Chairman & Chief Promoter and Member of Scientific Advisory Board40.6yrs₹148.50m26.37%
₹ 37.5b
Davuluri Rao
Vice Chairman & CEO11yrs₹148.30m3.3%
₹ 4.7b
Davuluri Rao
Vice Chairman & MD15.2yrs₹148.30m2.24%
₹ 3.2b
Abhijit Majumdar
Chief Financial Officer1.8yrsno datano data
Sharadsrikar Kotturi
Chief Scientific Officer & Member of Scientific Advisory Boardless than a yearno datano data
Sarada Bhamidipati
Company Secretary & Compliance Officer12.6yrsno datano data
Sudheer Yarabolu
Senior VP of Global Head Sales & BDno datano datano data
Hemchandra Peruvelli
Chief Human Resources Officerno datano datano data
Y. Sudheer
Senior Vice President of Global API Salesno datano datano data
N. Sundar
Chief Procurement Officerno data₹6.81mno data
Shashank Mahashabde
President of Business Development & Contract Manufacturingno datano datano data
Ashutosh Sinha
Chief Quality Officerless than a yearno datano data

3.9yrs

Average Tenure

54yo

Average Age

Experienced Management: NEULANDLAB's management team is considered experienced (3.9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Davuluri Rama Rao
Executive Chairman & Chief Promoter and Member of Scientific Advisory Board40.6yrs₹148.50m26.37%
₹ 37.5b
Davuluri Rao
Vice Chairman & CEO21.1yrs₹148.30m3.3%
₹ 4.7b
Davuluri Rao
Vice Chairman & MD15.2yrs₹148.30m2.24%
₹ 3.2b
Sharadsrikar Kotturi
Chief Scientific Officer & Member of Scientific Advisory Boardno datano datano data
Prasad Menon
Independent Director1.8yrs₹2.90mno data
Homi Khusrokhan
Non-Executive Independent Director5.5yrs₹3.24mno data
Sugata Sircar
Independent Director1.1yrs₹2.82mno data
Christopher Cimarusti
Non-Executive Director & Member of Scientific Advisory Board14.8yrs₹2.85mno data
Mauricio Futran
Member of Scientific Advisory Boardno datano datano data
Nirmala Murthy
Non-Executive Independent Director9.3yrs₹3.16mno data
Pallavi Bakhru
Independent Director1.1yrs₹2.82mno data
Pushpa Singh
Member of Scientific Advisory Boardno datano datano data

9.3yrs

Average Tenure

78yo

Average Age

Experienced Board: NEULANDLAB's board of directors are considered experienced (9.3 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.